{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:25:19Z","timestamp":1786980319125,"version":"build-2736575974"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T00:00:00Z","timestamp":1732665600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T00:00:00Z","timestamp":1732665600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100013227","name":"Health Promotion Administration, Ministry of Health and Welfare","doi-asserted-by":"publisher","award":["22AA2003"],"award-info":[{"award-number":["22AA2003"]}],"id":[{"id":"10.13039\/100013227","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Gastroenterol"],"published-print":{"date-parts":[[2025,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The patients taking direct oral anticoagulants (DOACs) are at high risk for developing ischemic stroke and delayed bleeding in upper gastrointestinal endoscopic submucosal dissection (ESD). We aimed to identify the optimal DOAC based on both adverse events in upper gastrointestinal ESD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A retrospective population-based cohort study was conducted using the Diagnosis Procedure Combination database in Japan. We included patients on a DOAC undergoing upper gastrointestinal ESD between 2012 and 2021. The primary outcomes were ischemic stroke occurring after upper gastrointestinal ESD and delayed bleeding in gastroduodenal and esophageal ESD. Inverse probability weightings were applied to balance the four DOAC groups (dabigatran, rivaroxaban, apixaban, and edoxaban), and logistic regression analyses were performed to compare the outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We analyzed 9729 patients on a DOAC undergoing upper gastrointestinal ESD. Ischemic stroke developed after upper gastrointestinal ESD in 1.4%, 0.7%, 0.6%, and 0.8% of patients taking dabigatran, rivaroxaban, apixaban, and edoxaban, respectively, after weighting. Rivaroxaban and apixaban showed significantly lower risk of ischemic stroke compared with dabigatran (odds ratio, 0.15 and 0.12, respectively) in standard doses. The delayed bleeding developed after gastroduodenal ESD in 7.6%, 14.6%, 19.2%, and 17.3% of patients taking each DOAC, respectively, with the lowest risk in dabigatran, followed by rivaroxaban. A similar pattern was observed in delayed bleeding in esophageal ESD (3.2%, 5.4%, 7.5%, and 5.5% in each DOAC), but with no significant results.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Rivaroxaban might be an optimal DOAC for upper gastrointestinal ESD showing a lower risk for both ischemic stroke and delayed bleeding.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00535-024-02171-2","type":"journal-article","created":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T07:46:11Z","timestamp":1732693571000},"page":"66-76","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Optimal direct oral anticoagulant for upper gastrointestinal endoscopic submucosal dissection"],"prefix":"10.1007","volume":"60","author":[{"given":"Yoshitaka","family":"Ono","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9717-0281","authenticated-orcid":false,"given":"Waku","family":"Hatta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunio","family":"Tarasawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yohei","family":"Ogata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroko","family":"Abe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isao","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutaka","family":"Hatayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyi","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaname","family":"Uno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoyuki","family":"Koike","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Imatani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shin","family":"Hamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Fujimori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiyohide","family":"Fushimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Masamune","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,27]]},"reference":[{"key":"2171_CR1","doi-asserted-by":"publisher","first-page":"1862","DOI":"10.1007\/s10620-014-3098-2","volume":"59","author":"JS Kim","year":"2014","unstructured":"Kim JS, Kim BW, Shin IS. Efficacy and safety of endoscopic submucosal dissection for superficial squamous esophageal neoplasia: a meta-analysis. Dig Dis Sci. 2014;59:1862\u20139. https:\/\/doi.org\/10.1007\/s10620-014-3098-2.","journal-title":"Dig Dis Sci"},{"key":"2171_CR2","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1111\/den.13531","volume":"32","author":"W Hatta","year":"2020","unstructured":"Hatta W, Gotoda T, Koike T, et al. History and future perspectives in Japanese guidelines for endoscopic resection of early gastric cancer. Dig Endosc. 2020;32:180\u201390. https:\/\/doi.org\/10.1111\/den.13531.","journal-title":"Dig Endosc"},{"key":"2171_CR3","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1055\/a-0577-2560","volume":"50","author":"ZP Qi","year":"2018","unstructured":"Qi ZP, Chen T, Li B, et al. Endoscopic submucosal dissection for early esophageal cancer in elderly patients with relative indications for endoscopic treatment. Endoscopy. 2018;50:839\u201345. https:\/\/doi.org\/10.1055\/a-0577-2560.","journal-title":"Endoscopy"},{"key":"2171_CR4","doi-asserted-by":"publisher","first-page":"412","DOI":"10.5009\/gnl19194","volume":"14","author":"W Hatta","year":"2020","unstructured":"Hatta W, Gotoda T, Koike T, et al. A recent argument for the use of endoscopic submucosal dissection for early gastric cancers. Gut Liver. 2020;14:412\u201322. https:\/\/doi.org\/10.5009\/gnl19194.","journal-title":"Gut Liver"},{"key":"2171_CR5","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1016\/j.gie.2014.12.010","volume":"81","author":"AT Committee","year":"2015","unstructured":"Committee AT, Maple JT, Abu Dayyeh BK, et al. Endoscopic submucosal dissection. Gastrointest Endosc. 2015;81:1311\u201325. https:\/\/doi.org\/10.1016\/j.gie.2014.12.010.","journal-title":"Gastrointest Endosc"},{"key":"2171_CR6","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1111\/j.1440-1746.2010.06503.x","volume":"26","author":"Y Urabe","year":"2011","unstructured":"Urabe Y, Hiyama T, Tanaka S, et al. Advantages of endoscopic submucosal dissection versus endoscopic oblique aspiration mucosectomy for superficial esophageal tumors. J Gastroenterol Hepatol. 2011;26:275\u201380. https:\/\/doi.org\/10.1111\/j.1440-1746.2010.06503.x.","journal-title":"J Gastroenterol Hepatol"},{"issue":"Suppl 1","key":"2171_CR7","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1111\/j.1443-1661.2012.01388.x","volume":"25","author":"H Isomoto","year":"2013","unstructured":"Isomoto H, Yamaguchi N, Minami H, et al. Management of complications associated with endoscopic submucosal dissection\/ endoscopic mucosal resection for esophageal cancer. Dig Endosc. 2013;25(Suppl 1):29\u201338. https:\/\/doi.org\/10.1111\/j.1443-1661.2012.01388.x.","journal-title":"Dig Endosc"},{"key":"2171_CR8","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.1111\/jgh.15944","volume":"37","author":"Y Horie","year":"2022","unstructured":"Horie Y, Horiuchi Y, Ishiyama A, et al. The effect of antithrombotic drug use on delayed bleeding with esophageal endoscopic resection. J Gastroenterol Hepatol. 2022;37:1792\u2013800. https:\/\/doi.org\/10.1111\/jgh.15944.","journal-title":"J Gastroenterol Hepatol"},{"key":"2171_CR9","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/j.gie.2016.06.033","volume":"84","author":"D Libanio","year":"2016","unstructured":"Libanio D, Costa MN, Pimentel-Nunes P, et al. Risk factors for bleeding after gastric endoscopic submucosal dissection: a systematic review and meta-analysis. Gastrointest Endosc. 2016;84:572\u201386. https:\/\/doi.org\/10.1016\/j.gie.2016.06.033.","journal-title":"Gastrointest Endosc"},{"key":"2171_CR10","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/j.gie.2018.05.002","volume":"88","author":"N Yahagi","year":"2018","unstructured":"Yahagi N, Kato M, Ochiai Y, et al. Outcomes of endoscopic resection for superficial duodenal epithelial neoplasia. Gastrointest Endosc. 2018;88:676\u201382. https:\/\/doi.org\/10.1016\/j.gie.2018.05.002.","journal-title":"Gastrointest Endosc"},{"key":"2171_CR11","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1055\/s-0044-102255","volume":"50","author":"T Tashima","year":"2018","unstructured":"Tashima T, Ohata K, Sakai E, et al. Efficacy of an over-the-scope clip for preventing adverse events after duodenal endoscopic submucosal dissection: a prospective interventional study. Endoscopy. 2018;50:487\u201396. https:\/\/doi.org\/10.1055\/s-0044-102255.","journal-title":"Endoscopy"},{"key":"2171_CR12","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1080\/00365521.2020.1867896","volume":"56","author":"K Hirasawa","year":"2021","unstructured":"Hirasawa K, Ozeki Y, Sawada A, et al. Appropriate endoscopic treatment selection and surveillance for superficial non-ampullary duodenal epithelial tumors. Scand J Gastroenterol. 2021;56:342\u201350. https:\/\/doi.org\/10.1080\/00365521.2020.1867896.","journal-title":"Scand J Gastroenterol"},{"key":"2171_CR13","doi-asserted-by":"publisher","first-page":"2769","DOI":"10.1111\/jgh.15536","volume":"36","author":"S Shiroma","year":"2021","unstructured":"Shiroma S, Hatta W, Tsuji Y, et al. Timing of bleeding and thromboembolism associated with endoscopic submucosal dissection for gastric cancer in Japan. J Gastroenterol Hepatol. 2021;36:2769\u201377. https:\/\/doi.org\/10.1111\/jgh.15536.","journal-title":"J Gastroenterol Hepatol"},{"key":"2171_CR14","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1136\/gutjnl-2019-319926","volume":"70","author":"W Hatta","year":"2021","unstructured":"Hatta W, Tsuji Y, Yoshio T, et al. Prediction model of bleeding after endoscopic submucosal dissection for early gastric cancer: BEST-J score. Gut. 2021;70:476\u201384. https:\/\/doi.org\/10.1136\/gutjnl-2019-319926.","journal-title":"Gut"},{"key":"2171_CR15","doi-asserted-by":"publisher","DOI":"10.1002\/deo2.60","volume":"2","author":"W Hatta","year":"2022","unstructured":"Hatta W, Koike T, Abe H, et al. Recent approach for preventing complications in upper gastrointestinal endoscopic submucosal dissection. DEN Open. 2022;2: e60. https:\/\/doi.org\/10.1002\/deo2.60.","journal-title":"DEN Open"},{"key":"2171_CR16","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1186\/s12913-020-5058-1","volume":"20","author":"KH Ho","year":"2020","unstructured":"Ho KH, van Hove M, Leng G. Trends in anticoagulant prescribing: a review of local policies in English primary care. BMC Health Serv Res. 2020;20:279. https:\/\/doi.org\/10.1186\/s12913-020-5058-1.","journal-title":"BMC Health Serv Res"},{"key":"2171_CR17","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.ejim.2023.08.007","volume":"118","author":"K Kaneda","year":"2023","unstructured":"Kaneda K, Yamashita Y, Morimoto T, et al. Anticoagulation strategies and long-term recurrence in patients with venous thromboembolism in the era of direct oral anticoagulants. Eur J Intern Med. 2023;118:59\u201372. https:\/\/doi.org\/10.1016\/j.ejim.2023.08.007.","journal-title":"Eur J Intern Med"},{"key":"2171_CR18","doi-asserted-by":"publisher","first-page":"2933","DOI":"10.1161\/STROKEAHA.118.020232","volume":"49","author":"GYH Lip","year":"2018","unstructured":"Lip GYH, Keshishian A, Li X, et al. Effectiveness and safety of oral anticoagulants among nonvalvular atrial fibrillation patients. Stroke. 2018;49:2933\u201344. https:\/\/doi.org\/10.1161\/STROKEAHA.118.020232.","journal-title":"Stroke"},{"key":"2171_CR19","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1007\/s10654-021-00751-7","volume":"36","author":"J Zhang","year":"2021","unstructured":"Zhang J, Wang X, Liu X, et al. Comparative effectiveness and safety of direct acting oral anticoagulants in nonvalvular atrial fibrillation for stroke prevention: a systematic review and meta-analysis. Eur J Epidemiol. 2021;36:793\u2013812. https:\/\/doi.org\/10.1007\/s10654-021-00751-7.","journal-title":"Eur J Epidemiol"},{"key":"2171_CR20","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.7326\/M22-0511","volume":"175","author":"WCY Lau","year":"2022","unstructured":"Lau WCY, Torre CO, Man KKC, et al. Comparative effectiveness and safety between apixaban, dabigatran, edoxaban, and rivaroxaban among patients with atrial fibrillation: a multinational population-based cohort study. Ann Intern Med. 2022;175:1515\u201324. https:\/\/doi.org\/10.7326\/M22-0511.","journal-title":"Ann Intern Med"},{"key":"2171_CR21","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/s10120-020-01105-0","volume":"24","author":"H Tomida","year":"2021","unstructured":"Tomida H, Yoshio T, Igarashi K, et al. Influence of anticoagulants on the risk of delayed bleeding after gastric endoscopic submucosal dissection: a multicenter retrospective study. Gastric Cancer. 2021;24:179\u201389. https:\/\/doi.org\/10.1007\/s10120-020-01105-0.","journal-title":"Gastric Cancer"},{"key":"2171_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/den.12183","volume":"26","author":"K Fujimoto","year":"2014","unstructured":"Fujimoto K, Fujishiro M, Kato M, et al. Guidelines for gastroenterological endoscopy in patients undergoing antithrombotic treatment. Dig Endosc. 2014;26:1\u201314. https:\/\/doi.org\/10.1111\/den.12183.","journal-title":"Dig Endosc"},{"key":"2171_CR23","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1620\/tjem.252.53","volume":"252","author":"K Tarasawa","year":"2020","unstructured":"Tarasawa K, Fujimori K, Fushimi K. Recombinant human soluble thrombomodulin contributes to a reduction in-hospital mortality of acute cholangitis with disseminated intravascular coagulation: a propensity score analyses of a Japanese Nationwide Database. Tohoku J Exp Med. 2020;252:53\u201361. https:\/\/doi.org\/10.1620\/tjem.252.53.","journal-title":"Tohoku J Exp Med"},{"key":"2171_CR24","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1186\/s13613-021-00928-z","volume":"11","author":"K Fujimori","year":"2021","unstructured":"Fujimori K, Tarasawa K, Fushimi K. Effectiveness of polymyxin B hemoperfusion for sepsis depends on the baseline SOFA score: a nationwide observational study. Ann Intens Care. 2021;11:141. https:\/\/doi.org\/10.1186\/s13613-021-00928-z.","journal-title":"Ann Intens Care"},{"key":"2171_CR25","first-page":"32","volume":"41","author":"GR Bramer","year":"1988","unstructured":"Bramer GR. International statistical classification of diseases and related health problems. Tenth revision. World Health Stat Q. 1988;41:32\u20136.","journal-title":"World Health Stat Q"},{"key":"2171_CR26","unstructured":"Ministry of Health, Labour and Welfare. https:\/\/shinryohoshu.mhlw.go.jp\/shinryohoshu\/. Accessed 15 April 2024."},{"key":"2171_CR27","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","volume":"40","author":"ME Charlson","year":"1987","unstructured":"Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373\u201383. https:\/\/doi.org\/10.1016\/0021-9681(87)90171-8.","journal-title":"J Chronic Dis"},{"key":"2171_CR28","doi-asserted-by":"publisher","first-page":"2864","DOI":"10.1001\/jama.285.22.2864","volume":"285","author":"BF Gage","year":"2001","unstructured":"Gage BF, Waterman AD, Shannon W, et al. Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. JAMA. 2001;285:2864\u201370. https:\/\/doi.org\/10.1001\/jama.285.22.2864.","journal-title":"JAMA"},{"key":"2171_CR29","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/j.je.2016.09.009","volume":"27","author":"H Yamana","year":"2017","unstructured":"Yamana H, Moriwaki M, Horiguchi H, et al. Validity of diagnoses, procedures, and laboratory data in Japanese administrative data. J Epidemiol. 2017;27:476\u201382. https:\/\/doi.org\/10.1016\/j.je.2016.09.009.","journal-title":"J Epidemiol"},{"key":"2171_CR30","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1186\/1471-230X-13-136","volume":"13","author":"T Takeuchi","year":"2013","unstructured":"Takeuchi T, Ota K, Harada S, et al. The postoperative bleeding rate and its risk factors in patients on antithrombotic therapy who undergo gastric endoscopic submucosal dissection. BMC Gastroenterol. 2013;13:136. https:\/\/doi.org\/10.1186\/1471-230X-13-136.","journal-title":"BMC Gastroenterol"},{"key":"2171_CR31","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1007\/s00535-021-01781-4","volume":"56","author":"H Abe","year":"2021","unstructured":"Abe H, Hatta W, Ogata Y, et al. Prevention of delayed bleeding with vonoprazan in upper gastrointestinal endoscopic treatment. J Gastroenterol. 2021;56:640\u201350. https:\/\/doi.org\/10.1007\/s00535-021-01781-4.","journal-title":"J Gastroenterol"},{"key":"2171_CR32","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1136\/gutjnl-2014-307552","volume":"64","author":"S Mochizuki","year":"2015","unstructured":"Mochizuki S, Uedo N, Oda I, et al. Scheduled second-look endoscopy is not recommended after endoscopic submucosal dissection for gastric neoplasms (the SAFE trial): a multicentre prospective randomised controlled non-inferiority trial. Gut. 2015;64:397\u2013405. https:\/\/doi.org\/10.1136\/gutjnl-2014-307552.","journal-title":"Gut"},{"key":"2171_CR33","doi-asserted-by":"publisher","first-page":"812","DOI":"10.14309\/ajg.0000000000002076","volume":"118","author":"C Hansen-Barkun","year":"2023","unstructured":"Hansen-Barkun C, Martel M, Douketis J, et al. Periprocedural management of patients with atrial fibrillation receiving a Direct Oral Anticoagulant Undergoing a Digestive Endoscopy. Am J Gastroenterol. 2023;118:812\u20139. https:\/\/doi.org\/10.14309\/ajg.0000000000002076.","journal-title":"Am J Gastroenterol"},{"key":"2171_CR34","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1097\/00001648-200009000-00011","volume":"11","author":"JM Robins","year":"2000","unstructured":"Robins JM, Hernan MA, Brumback B. Marginal structural models and causal inference in epidemiology. Epidemiology. 2000;11:550\u201360. https:\/\/doi.org\/10.1097\/00001648-200009000-00011.","journal-title":"Epidemiology"},{"key":"2171_CR35","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1111\/joim.12197","volume":"275","author":"T Sturmer","year":"2014","unstructured":"Sturmer T, Wyss R, Glynn RJ, et al. Propensity scores for confounder adjustment when assessing the effects of medical interventions using nonexperimental study designs. J Intern Med. 2014;275:570\u201380. https:\/\/doi.org\/10.1111\/joim.12197.","journal-title":"J Intern Med"},{"key":"2171_CR36","doi-asserted-by":"publisher","first-page":"3388","DOI":"10.1002\/sim.5753","volume":"32","author":"DF McCaffrey","year":"2013","unstructured":"McCaffrey DF, Griffin BA, Almirall D, et al. A tutorial on propensity score estimation for multiple treatments using generalized boosted models. Stat Med. 2013;32:3388\u2013414. https:\/\/doi.org\/10.1002\/sim.5753.","journal-title":"Stat Med"},{"key":"2171_CR37","doi-asserted-by":"publisher","first-page":"3083","DOI":"10.1002\/sim.3697","volume":"28","author":"PC Austin","year":"2009","unstructured":"Austin PC. Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples. Stat Med. 2009;28:3083\u2013107. https:\/\/doi.org\/10.1002\/sim.3697.","journal-title":"Stat Med"},{"issue":"271\u201382","key":"2171_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2023.09.012","volume":"22","author":"N Yoshida","year":"2024","unstructured":"Yoshida N, Hayashi Y, Togo D, et al. An analysis of delayed bleeding in cases of colorectal endoscopic submucosal dissection due to types of direct oral anticoagulants in Japan. Clin Gastroenterol Hepatol. 2024;22(271\u201382): e3. https:\/\/doi.org\/10.1016\/j.cgh.2023.09.012.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2171_CR39","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1177\/0091270005274550","volume":"45","author":"J Stangier","year":"2005","unstructured":"Stangier J, Eriksson BI, Dahl OE, et al. Pharmacokinetic profile of the oral direct thrombin inhibitor dabigatran etexilate in healthy volunteers and patients undergoing total hip replacement. J Clin Pharmacol. 2005;45:555\u201363. https:\/\/doi.org\/10.1177\/0091270005274550.","journal-title":"J Clin Pharmacol"},{"key":"2171_CR40","doi-asserted-by":"publisher","first-page":"e308","DOI":"10.1097\/MJT.0000000000000599","volume":"26","author":"T Bolek","year":"2019","unstructured":"Bolek T, Samos M, Stanciakova L, et al. The impact of proton pump inhibition on Dabigatran levels in patients with atrial fibrillation. Am J Ther. 2019;26:e308\u201313. https:\/\/doi.org\/10.1097\/MJT.0000000000000599.","journal-title":"Am J Ther"},{"key":"2171_CR41","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1111\/den.13184","volume":"30","author":"M Kato","year":"2018","unstructured":"Kato M, Uedo N, Hokimoto S, et al. Guidelines for gastroenterological endoscopy in patients undergoing antithrombotic treatment: 2017 appendix on anticoagulants including direct oral anticoagulants. Dig Endosc. 2018;30:433\u201340. https:\/\/doi.org\/10.1111\/den.13184.","journal-title":"Dig Endosc"}],"container-title":["Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-024-02171-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00535-024-02171-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-024-02171-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T22:02:12Z","timestamp":1771279332000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00535-024-02171-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,27]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["2171"],"URL":"https:\/\/doi.org\/10.1007\/s00535-024-02171-2","relation":{},"ISSN":["0944-1174","1435-5922"],"issn-type":[{"value":"0944-1174","type":"print"},{"value":"1435-5922","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,27]]},"assertion":[{"value":"29 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors have no conflicts of interest to be declared.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Patient consent for publication"}}]}}